Specialty

Prostate Cancer Clinical Trial Update With Dr. Keith Crawford. Visit Prostate Health Education Network for more information on prostate cancer and clinical trials.

December 2019 Clinical Trials Update With Dr. Keith Crawford from the Prostate Health Education Network Visit http://www.prostatehealthed.org/phen_tv_video.php?tv_id=291 for monthly updates on clinical trials

The 2019 PHEN Summit was moderated by Dr. James Roberson and speakers included Brandon Mahal, MD and Daniel George, MD discussing the African American prostate cancer health disparity. Visit http://prostatehealthed.org/ for more from PHEN on prostate cancer and clinical trials.

On December 16, 2019, the Food and Drug Administration approved enzalutamide (XTANDI, Astellas Pharma Inc.) for patients with metastatic castration-sensitive prostate cancer (mCSPC). FDA previously approved enzalutamide for patients with castration-resistant prostate cancer. Efficacy was investigated in ARCHES (NCT02677896), a trial enrolling 1150 patients with mCSPC randomized (1:1) to receive either enzalutamide orally 160 mg once...

A recent study suggests that there may be a link between MS progression and blood lipids in MS patients who are overweight or obese.  The study  published in the Lancet journal EBioMedicine supports previous research that hints food, diet, and exercise can help affect disease progression in MS patients. The study was conducted by researchers at the...

Coronary artery disease is the most common type of heart disease. Atherosclerosis causes the arteries to narrow and harden, cutting off blood supply to the heart.  Not only is coronary artery disease more prevalent in African-Americans, it also starts at an earlier age. Studies have shown that African-Americans also have the highest mortality rates from...

A Baylor University study found that a significantly higher number of African Americans had peripheral artery disease (PAD) compared to Hispanics and whites in patients over the age of 55. Peripheral artery disease is defined as atherosclerosis of the abdominal aorta and the arteries in the legs. PAD can be asymptomatic or symptomatic. Symptoms of...

Most of the latest Multiple Sclerosis treatments cater to relapsing and remitting MS patients. Until Roche’s blockbuster drug Ocrevus launched for progressive MS, patients with progressive and advanced multiple sclerosis had not benefitted as much from therapeutic innovations in the MS space. Renowned neurologist, Robert Fox indicates that he always is very transparent with newly...

Chronic lymphocytic leukemia (CLL) is a cancer that occurs when the bone marrow makes too many lymphocytes, a type of white blood cell. CLL usually grows slowly compared to other leukemias, and it may not cause symptoms for some time. CLL is one of four main types of leukemia. It is the second most common...